CD8A and neoplasm: Strikingly, dual ICB abrogated tumor growth in FibΔZeb1 mice combined with a more robust increase in CD8+ T cells, ablation of FOXP3+ cells, and reduced PD-L1 expression (Figs. 5C,D and  EV5E).